Invivyd Inc. (IVVD)

NASDAQ HEALTHCARE

$1.14 +0.89% RSI 45 Neutral Add Alert

Moving Averages

SMA 200

$1.66

Price below

Company Profile

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$427.03M

P/E Ratio

None

EPS

$-0.3

Beta

0.714